PT - JOURNAL ARTICLE AU - Tiffany X. Chen AU - Ana Pinharanda AU - Keiko Yasuma-Mitobe AU - Elaine Lee AU - Natalie A. Steinemann AU - Jaeseung Hahn AU - Lydia Wu AU - Stavros Fanourakis AU - Darcy S. Peterka AU - Elizabeth M.C. Hillman TI - Evaluation of at-home methods for N95 filtering facepiece respirator decontamination AID - 10.1101/2021.01.05.20248590 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.05.20248590 4099 - http://medrxiv.org/content/early/2021/01/06/2021.01.05.20248590.short 4100 - http://medrxiv.org/content/early/2021/01/06/2021.01.05.20248590.full AB - Shortages in N95 filtering facepiece respirators (FFRs) are significant as FFRs are essential for the protection of healthcare professionals and other high-risk groups against Coronavirus Disease of 2019 (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2. In response to these shortages during the ongoing COVID-19 pandemic, the Food and Drug Administration issued an Emergency Use Authorization (EUA) permitting FFR decontamination and reuse. However, although industrial decontamination services are available at some large institutions, FFR decontamination is not widely available.Effective FFR decontamination must 1) deactivate the virus; 2) preserve FFR integrity, specifically fit and filtering capability; and 3) be non-toxic and safe. Here we identify and compare at-home methods for heat-based FFR decontamination that meet these requirements, but utilize common household appliances. Our results identify viable protocols for simple and accessible FFR decontamination, while also highlighting methods that may jeopardize FFR integrity and should be avoided.One sentence summary Survey of at-home methods for N95 respirator decontamination using heat and evaluation of their effects on N95 respirator integrity.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study does not classify as a clinical trialFunding StatementThe Zuckerman Mind Brain Behavior Institute, Columbia University provided funding to support this project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Columbia University Institutional Review Board reviewed this study's protocol and determined that ethical approval could be waived (IRB reference AAAT5503)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the main text or the supplementary materials.